Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02094170 · ClinicalTrials.gov registry record
Global Positioning System (GPS) Exposure to Environments & Relations With Biomarkers of Cancer Risk
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 601
- Enrollment target
NCT02094170: Completed study, sponsored by University of California, San Diego.
NCT02094170 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 601 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02094170 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 601 participants
- Enrollment target
Study Summary
The prevalence of overweight and obesity are increasing worldwide. In the U.S., approximately 85,000 new cancer cases per year are related to obesity. Understanding lifestyle behaviors, their causes, and relations to cancer are critical. Where people spend their time during the day may be related to their risk of getting cancer. This project will assess behaviors in different locations across the day and relate exposure to different environments to biological outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 601 participants |
| Start Date | 2014-07 |
| Est. Completion | 2017-09-29 |
What the finished NCT02094170 record still lists
NCT02094170 is an observational study that tracks outcomes without assigning an intervention. The registered 601 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02094170 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02094170 about?
NCT02094170 is a clinical study titled "Global Positioning System (GPS) Exposure to Environments & Relations With Biomarkers of Cancer Risk". The prevalence of overweight and obesity are increasing worldwide. In the U.S., approximately 85,000 new cancer cases per year are related to obesity. Understanding lifestyle behaviors, their causes, and relations to cancer are critical. Where people spend their time during the day may be related to...
What is the current status of trial NCT02094170?
This trial is currently completed. The enrollment target is 601 participants. The study started on 2014-07. Estimated completion is 2017-09-29.
Who is sponsoring clinical trial NCT02094170?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia